Form 4 for CRL Charles River Laboratories
Accepted 2023-08-14 00:00:00 ET · period of report 2023-08-10 · accession 0001127602-23-022486 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-08-14 | 2023-08-10 | CRL | Knell Michael Gunnar | CAO, CSVP | S - Sale+OE | $216.54 | -1,471 | 9,940 | -13% | -$318.5K |
| D | 2023-08-14 | 2023-08-10 | CRL | Knell Michael Gunnar | CAO, CSVP | M - OptEx | $144.67 | +1,471 | 11.4K | +15% | +$212.8K |
| D | 2023-08-14 | 2023-08-10 | CRL | Knell Michael Gunnar | CAO, CSVP | M - OptEx | $0.00 | -1,471 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-08-10 | S | D | 1,471 | $216.54 | 9,940 | D | — | — | |
| 2 | Common | Common Stock | 2023-08-10 | M | A | 1,471 | $144.67 | 11,411 | D | — | — | |
| 3 | Derivative | Stock Options (Right to Buy) | 2023-08-10 | M | D | 1,471 | $0.00 | 0 | D | $144.67 · 2020-02-22 to 2024-02-22 | 1,471 Common Stock |